Endometrial

Pathologic and Treatment Outcomes Among a Geriatric Population of Endometrial Cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of LAP2
Erin A. Bishop, James J. Java, Kathleen N. Moore, Joan L. Walker

International Journal of Gynecologic Cancer May 2017, 27 (4) 730-737; DOI: 10.1097/IGC.0000000000000947
Effect of Physical Activity on Quality of Life as Perceived by Endometrial Cancer Survivors: A Systematic Review
Oluwole Adeyemi Babatunde, Swann A. Adams, Olubunmi Orekoya, Karen Basen-Engquist, Susan E. Steck

International Journal of Gynecologic Cancer Nov 2016, 26 (9) 1727-1740; DOI: 10.1097/IGC.0000000000000821
The Value of Gynecologic Cancer Follow-Up: Evidence-Based Ignorance?
Henrik Lajer, Mette B. Jensen, Jannie Kilsmark, Jens Albæk, Danny Svane, Mansoor R. Mirza, Poul F. Geertsen, Diana Reerman, Kåre Hansen, Maya C. Milter, Ole Mogensen

International Journal of Gynecologic Cancer Oct 2010, 20 (8) 1307-1320; DOI: 10.1111/IGC.0b013e3181f3bee0
Is there a role for neoadjuvant chemotherapy in the treatment of stage IV serous endometrial carcinoma?
E. Despierre, P. Moerman, I. Vergote, F. Amant

International Journal of Gynecologic Cancer Jan 2006, 16 (Suppl 1) 273-277; DOI: 10.1136/ijgc-00009577-200602001-00044
The Use of Lymph Vessel Markers to Predict Endometrial Cancer Outcome
Ingrid Vandenput, Thomas Vanhove, Ben Van Calster, Toon Van Gorp, Philippe Moerman, Godelieve Verbist, Ignace Vergote, Frédéric Amant

International Journal of Gynecologic Cancer Apr 2010, 20 (3) 363-367; DOI: 10.1111/IGC.0b013e3181d4a0b9

Log in using your username and password

Main menu

Log in using your username and password

You are here

Endometrial